“I choose the Genius™ exam because it's more accurate than 2D mammograms.”

SHERYL CROW
Breast Cancer Survivor

Better, earlier breast cancer detection for women of all ages and breast densities.*1-6

Let us help you find a Genius™ exam near you. Enter your email and zip code and we’ll send you a list of nearby facilities.

home-tech-patient

Did you know that 1 out of every 8 women you know will likely develop breast cancer?8

If caught early, the 5-year survival rate is almost 100%.9

  • The Genius™ 3D Mammography™ exam is the only mammogram FDA approved as superior for women with dense breasts compared to 2D mammography alone.1-2
  • Only the Genius™ 3D Mammography™ exam finds 20-65% more invasive breast cancers compared to 2D alone.10
  • Studies show that Genius™ 3D Mammography™ exams reduce callbacks by up to 40%.2,5
  • Available in all 50 states.

The Genius™ 3D Mammography™ exam is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set.

The Genius™ exam is only available on the Hologic® 3D Mammography™ system.

Make sure your next mammogram is a Genius™ 3D Mammography™ exam.

Find a Genius exam near you

* Compared to 2D mammography alone.

  1. FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005

  2. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.

  3. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736.

  4. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.

  5. Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.

  6. McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43.

  7. Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr 26;315(16):1784-6.

  8. Breastcancer.org. US breast cancer statistics. Breastcancer.org. http://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed on: May 25, 2016.

  9. National Breast Cancer Foundation, Inc. Stages 0 & 1: what does is mean to have stage 1 breast cancer? National Breast Cancer Foundation, Inc. http://www.nationalbreastcancer.org/breast-cancer-stage-0- and-1. Accessed on: March 31, 2015.

  10. Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D(TM) mammograms acquired with the Hologic 3D Mammography(TM) System versus women receiving 2D FFDM mammograms only.